Section Head: Electrophysiology and Pacing /Cleveland Clinic
Cardiology
Dr. Bruce D. Lindsay, MD
|
|
Give Review
Bruce Lindsay works in the field of Cardiology. He graduated from Jefferson Medical College. He has 4 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Bruce D. Lindsay is a published doctor as well. He has 62 publications published. The latest was: Using a novel wireless system in monitoring patients after the atrial fibrillation ablation procedure: The iTransmit study. Bruce Lindsay is registered with Medicare and accepts Medicare payments.
Publications
- Using a novel wireless system in monitoring patients after the Atrial fibrillation ablation procedure: The iTransmit study.
- Assessing Risk of Inadequate DeFibrillation Safety Margin: The Strengths and Limitations of the NCDR ICD Registry.
- Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality.
- Challenges of diagnosis and risk stratification in patients with arrhythmogenic right ventricular Cardiomyopathy/dysplasia.
- Efficacy of the CHADS2 Scoring System to Assess Left Atrial Thrombogenic Milieu Risk Before Cardioversion of Non-Valvular Atrial Fibrillation.
- Spontaneous Dissociated Firing from the Pulmonary Veins during Ablation of Paroxysmal Atrial Fibrillation: Implications and Impact on Arrhythmia-Free Survival.
- Characteristics, treatment, and outcomes of periprocedural cerebrovascular accidents during electrophysiologic procedures.
- Remote monitoring of cardiovascular devices: a time and activity analysis.
- Perspective on Cost-Effective Utilization of Cardiac Resynchronization Therapy.
- Every life counts.
- Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.
- Transesophageal Echocardiography and Cardioversion Trends in Patients with Atrial Fibrillation: A 10-Year Survey.
- Phosphodiesterase-4 activity: a critical modulator of Atrial contractility and arrhythmogenesis.
- Indications for TEE Before Cardioversion for Atrial Fibrillation: Implications for Appropriateness Criteria.
- The impact of left ventricular size on response to cardiac resynchronization therapy.
- Noninvasive electroanatomic mapping of human ventricular Arrhythmias with electrocardiographic imaging.
- Radiofrequency ablation of atrial fibrillation in patients with mechanical mitral Valve prostheses safety, feasibility, electrophysiologic findings, and outcomes.
- Guidance for the Heart rhythm society pertaining to interactions with industry endorsed by the Heart rhythm society on april 26, 2011.
- Role of Transesophageal Echocardiography Compared to Computed Tomography in Evaluation of Pulmonary Vein Ablation for Atrial Fibrillation (ROTEA study).
- Plasma B-type natriuretic Peptide levels and recurrent arrhythmia after successful ablation of lone Atrial fibrillation.
- Should industry share a greater burden for the cost of device recalls?
- Natural History and Long Term Outcomes of Ablated Atrial Fibrillation.
- The QRS Narrowing Index Predicts Reverse Left Ventricular Remodeling Following Cardiac Resynchronization Therapy.
- Vernakalant: additional evidence for safety and efficacy for new onset Atrial fibrillation.
- Noninvasive characterization of epicardial activation in humans with diverse Atrial fibrillation patterns.
- Noninvasive real-time mapping of an incomplete Pulmonary vein isolation using electrocardiographic imaging.
- Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.
- Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.
- Characterization of super-response to cardiac resynchronization therapy.
- Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction.
- Deleterious effects of right ventricular pacing.
- Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with Atrial fibrillation undergoing transesophageal echocardiography before pulmonary vei...
- CCEP fellowship training requirements: Flexibility should be an advantage.
- Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.
- Should catheter ablation be the first line of treatment for Atrial fibrillation?
- Eliminating triggers of ventricular Fibrillation: the past, present, and future.
- Prediction of ventricular tachyArrhythmias by intracardiac repolarization variability analysis.
- Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures.
- Are Acute phase protein levels the link between atrial arrhythmias and inflammation?
- Focal and macroreentrant Atrial tachycardia: from bench to bedside and back to the bench again.
- Sustained polymorphic Arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators.
- A review of spinal injuries in the invasive cardiologist II: prevention and treatment.
- Review of the registry's first year, data collected, and future plans.
- Is pulmonary vein antrum isolation a critical determinant of recurrent Arrhythmias after ablation of atrial fibrillation?
- A review of spinal injuries in the invasive cardiologist: part 1. Biomechanics and pain generation.
- Focal Atrial tachycardia after pulmonary vein isolation: noninvasive mapping with electrocardiographic imaging (ECGI).
- The importance of retrospective analyses of adverse outcomes.
- Poor prognosis for patients with chronic kidney Disease despite ICD therapy for the primary prevention of sudden death.
- Life-threatening malfunction of implantable cardiac devices.
- Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive Cardiomyopathy.
- Smokers are at markedly increased risk of appropriate defibrillator shocks in a primary prevention population.
- Relation of T-wave alternans to regional left ventricular dysfunction and eccentric hypertrophy secondary to Coronary heart disease.
- Radiofrequency ablation of atrioventricular nodal reentrant tachycardia using a novel magnetic guidance system compared with a conventional approach.
- Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana.
- A minimally invasive surgical treatment for inappropriate sinus tachycardia.
- Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, Cardiomyopathy, and a negative electrophysiologic study.
- T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival.
- Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced Heart failure.
- Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications.
- Magnetic guidance system for cardiac electrophysiology: a prospective trial of safety and efficacy in humans.
- Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994?
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
University Of Michigan
Barnes Jewish Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
University of Michigan Hospitals and Health Centers -
Jefferson Medical College
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1316964828 | |
| NPPES Provider LastName | LINDSAY | |
| NPPES Provider FirstName | BRUCE | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 550.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316964828 |
| Last Name Of The Provider | LINDSAY |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
Dr. Shyam Bhakta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David O. Taylor, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Austin A. Halle III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amar Krishnaswamy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benico Barzilai, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David J. Frid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor Hajjar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khosrow Dorosti, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saptarsi M. Haldar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Schnell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Kutoloski, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce L. Wilkoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Albert L. Waldo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khalid Abozguia, MD |
|
|
Dr. Mohamed A. Bassiouny, MD |
|
|
Dr. John W. Rickard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elad Asher, MD |
|
|
Dr. Abraham D. Abernethy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parag R. Patel, MD |
|
|
Dr. Ali Rabah, MD |